{"id":"NCT01060072","sponsor":"Bausch & Lomb Incorporated","briefTitle":"Evaluation of Loteprednol Etabonate Versus Vehicle for the Treatment of Inflammation and Pain Following Cataract Surgery","officialTitle":"A Randomized, Multicenter, Double-Masked, Parallel-Group Clinical Safety and Efficacy Evaluation of Loteprednol Etabonate, 0.5% Versus Vehicle for the Treatment of Inflammation and Pain Following Cataract Surgery","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-02","primaryCompletion":"2010-09","completion":"2010-10","firstPosted":"2010-02-02","resultsPosted":"2012-01-13","lastUpdate":"2012-01-13"},"enrollment":407,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Inflammation","Pain"],"interventions":[{"type":"DRUG","name":"Loteprednol etabonate","otherNames":[]},{"type":"DRUG","name":"Vehicle of Loteprednol Etabonate","otherNames":[]}],"arms":[{"label":"Loteprednol etabonate","type":"EXPERIMENTAL"},{"label":"Vehicle","type":"PLACEBO_COMPARATOR"}],"summary":"This study is being conducted to compare the safety and efficacy of loteprednol etabonate to vehicle for the treatment of postoperative inflammation and pain following cataract surgery.","primaryOutcome":{"measure":"Resolution of Anterior Chamber Cells.","timeFrame":"Visit 5 (Postoperative day 8)","effectByArm":[{"arm":"Loteprednol Etabonate","deltaMin":64,"sd":null},{"arm":"Vehicle","deltaMin":28,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":4},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["24136301"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":206},"commonTop":["Anterior Chamber Inflammation","Eye Pain"]}}